In June of 2015, Telerx launched C3i Healthcare Connections – a division 100% focused on life sciences. Combining the best of Telerx’s Healthcare ConneXions, Sentrx, and C3i, Inc., C3i Healthcare Connections is your partner of choice in the healthcare and life sciences industry.
Telerx was founded in 1980, and has been focused on delivering the ultimate customer experience for longer than many of our competitors have been in business. It began with an innovative marketing technique that harnessed the cost-effectiveness of telephones to deliver critical communications to our clients’ customers: doctors, nurses, and pharmacists. By hiring nurses and pharmacists — a practice pioneered by Telerx — we were able to communicate more effectively, helping our clients launch new products, sustain existing ones, and increase market penetration. Our role soon expanded to include patient coaching and counseling as compliance became a critical factor in helping to improve patient outcomes.
By the early ’90s, we leveraged our experience and expertise in handling complex and sensitive customer interactions to other industries, including consumer packaged and durable goods.
In 1994, we became a wholly-owned, independent subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Merck is known as MSD outside the United States and Canada), giving us the added benefit of being able to focus on our quality of service without having to make the kinds of sacrifices similarly sized companies might have to make due to cost constraints.
C3i Healthcare Connections clients’ data are safe and isolated from our parent company. C3i Healthcare Connections has established and maintains robust organizational, operational and technical safeguards to protect client data and confidential information and to ensure our operational autonomy.
Over the next two decades, as our clients’ needs grew, so did Telerx. In addition to adding several new facilities in the US, we completed two strategic acquisitions. In 2013, Telerx acquired Sentrx Safety Solutions, an industry leading provider of pharmacovigilance services. This strategic acquisition enabled us to provide a full suite of drug safety solutions to the life sciences marketplace.
The following year, Telerx acquired C3i, Inc. – the leading provider of technical support services for the life sciences industry. With operations in North America, Europe, India and China, the acquisition of C3i, took Telerx global – enabling us to support clients in their local markets and in their local language.
Today we are supporting our ever-growing roster of clients 24/7, in over 100 countries, with over 30 languages.